icometrix announces collaboration with Japanese Micron

“We are very happy to partner with Micron and to help more radiologists, clinicians and patients in Japan”, says Hogne Ulla, Business Development Director at icometrix. “Japan has several world-leading hospitals and research institutions. Unfortunately, there is also a high number of patients with brain disorders. By 2025, it is expected that there will be 7 million dementia patients in Japan alone”, Ulla continues.

Having years of experience as an imaging contract research organization (CRO) for the pharmaceutical industry, Micron Inc. has built strong relationships with the Japanese hospital network and leading physicians. “For more than a decade, we have served as a bridge between pharmaceutical companies and hospitals”, says Michita Sato, CEO of Micron. “This has given us valuable insights into the needs of doctors and patients.”

Michita Sato further highlights the fit between the two companies.

“It is an honor for us to be able to work with the world leading company in brain imaging measures. The world of radiology is clearly changing from a qualitative to a quantitative one, for the benefit of the patient”, Michita Sato continues. “Through the collaboration with icometrix, we are proud to be able to provide best-in-class brain imaging reporting to our Japanese institutions, doctors and patients”.

CEO of icometrix, Wim Van Hecke, stresses the importance of the collaboration. “This strategic collaboration with Micron is part of our fast growth”, he comments. “The number of hospitals and imaging centers using our brain reports is increasing rapidly. We have been mainly active in the US and Europe. This partnership with Micron allows us to accelerate our growth in Asia, a very important market for us. In addition, thanks to the excellent reputation and professional services of Micron, we’ll be able to help our Japanese customers in the best possible way”, says Van Hecke.